Washington University School of Medicine (Site 1022) — St Louis, Missouri

Washington University School of Medicine (Site 1022) is a clinical research site located in St Louis, Missouri, United States 63110.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Washington University School of Medicine (Site 1022) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Washington University School of Medicine (Site 1022)?

Washington University School of Medicine (Site 1022) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Washington University School of Medicine (Site 1022) conducted?

Washington University School of Medicine (Site 1022) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Washington University School of Medicine (Site 1022) accredited by Crixeo Health?

Washington University School of Medicine (Site 1022) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Washington University School of Medicine (Site 1022)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.